Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SGN-B6A

Copy Product Info
😃Good
Catalog No. T9901A-484

SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.

SGN-B6A

SGN-B6A

Copy Product Info
😃Good
Catalog No. T9901A-484
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy SGN-B6A | purchase SGN-B6A | SGN-B6A cost | order SGN-B6A